Title : Different effect of unfractionated heparin and enoxaparin on circulating proangiogenic factors during hemodialysis: A cross-over study.

Pub. Date : 2007 Nov

PMID : 17920287






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 VEGF(165) significantly decreased during both enoxaparin (chi(2) ANOVA=33.0, P<10(-6)) and UFH (chi(2) ANOVA=27.2, P<10(-6)) anticoagulated HD, while over-HD bFGF remained stable regardless of the type of heparin. Enoxaparin vascular endothelial growth factor A Homo sapiens
2 The switch from enoxaparin to UFH treatment was connected with 34% VEGF(165) decrease after 180min of HD and had no impact on bFGF. Enoxaparin vascular endothelial growth factor A Homo sapiens
3 CONCLUSION: The traditional UFH regimen, in contrast to enoxaparin treatment, is connected with dose-depended VEGF(165) decrease during HD procedure. Enoxaparin vascular endothelial growth factor A Homo sapiens